Which has preferable valuation and earnings, MEDP or SHC?

Medpace has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medpace $2.53B 6.85 $451.12M $17.06 36.40 Sotera Health $1.16B 4.71 $77.94M $0.57 33.69

Is MEDP or SHC more profitable?

Medpace has a net margin of 17.67% compared to Sotera Health's net margin of 13.44%. Medpace's return on equity of 110.15% beat Sotera Health's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.67% 110.15% 24.84% Sotera Health 13.44% 40.12% 7.55%

Does the media favor MEDP or SHC?

In the previous week, Medpace had 5 more articles in the media than Sotera Health. MarketBeat recorded 8 mentions for Medpace and 3 mentions for Sotera Health. Medpace's average media sentiment score of 1.35 beat Sotera Health's score of 0.93 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, RVTY or SHC?

Revvity has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Revvity $2.86B 5.82 $241.20M $2.10 70.98 Sotera Health $1.16B 4.71 $77.94M $0.57 33.69

Is RVTY or SHC more profitable?

Sotera Health has a net margin of 13.44% compared to Revvity's net margin of 8.16%. Sotera Health's return on equity of 40.12% beat Revvity's return on equity. Company Net Margins Return on Equity Return on Assets Revvity 8.16% 8.34% 5.01% Sotera Health 13.44% 40.12% 7.55%

Does the media refer more to RVTY or SHC?

In the previous week, Revvity had 11 more articles in the media than Sotera Health. MarketBeat recorded 14 mentions for Revvity and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.93 beat Revvity's score of 0.78 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revvity 4 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, ICLR or SHC?

Icon has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Icon $8.25B 1.61 $229.34M $4.26 40.63 Sotera Health $1.16B 4.71 $77.94M $0.57 33.69

Is ICLR or SHC more profitable?

Sotera Health has a net margin of 13.44% compared to Icon's net margin of 3.99%. Sotera Health's return on equity of 40.12% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Icon 3.99% 8.02% 4.56% Sotera Health 13.44% 40.12% 7.55%

Does the media refer more to ICLR or SHC?

In the previous week, Sotera Health had 1 more articles in the media than Icon. MarketBeat recorded 3 mentions for Sotera Health and 2 mentions for Icon. Icon's average media sentiment score of 1.32 beat Sotera Health's score of 0.93 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, TECH or SHC?

Bio-Techne has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bio-Techne $1.22B 9.35 $181.86M $1.15 62.96 Sotera Health $1.16B 4.71 $77.94M $0.57 33.69

Is TECH or SHC more profitable?

Bio-Techne has a net margin of 14.97% compared to Sotera Health's net margin of 13.44%. Sotera Health's return on equity of 40.12% beat Bio-Techne's return on equity. Company Net Margins Return on Equity Return on Assets Bio-Techne 14.97% 13.23% 10.61% Sotera Health 13.44% 40.12% 7.55%

Does the media prefer TECH or SHC?

In the previous week, Bio-Techne had 9 more articles in the media than Sotera Health. MarketBeat recorded 12 mentions for Bio-Techne and 3 mentions for Sotera Health. Bio-Techne's average media sentiment score of 1.14 beat Sotera Health's score of 0.93 indicating that Bio-Techne is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Sotera Health (SHC) Competitors

$19.18 -0.15 (-0.75%)

As of 01:13 PM Eastern

Compare

SHC vs. MEDP, RVTY, ICLR, CRL, and TECH

Should you buy Sotera Health stock or one of its competitors? Sotera Health's main competitors and comparable companies include Medpace (MEDP), Revvity (RVTY), Icon (ICLR), Charles River Laboratories International (CRL), and Bio-Techne (TECH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Sotera Health compare to Medpace?

Medpace (NASDAQ:MEDP) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

78.0% of Medpace shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 20.5% of Medpace shares are held by insiders. Comparatively, 15.4% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Medpace had 5 more articles in the media than Sotera Health. MarketBeat recorded 8 mentions for Medpace and 3 mentions for Sotera Health. Medpace's average media sentiment score of 1.35 beat Sotera Health's score of 0.93 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medpace has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	6.85	$451.12M	$17.06	36.40
Sotera Health	$1.16B	4.71	$77.94M	$0.57	33.69

Medpace has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, suggesting that its stock price is 77% more volatile than the broader market.

Medpace has a net margin of 17.67% compared to Sotera Health's net margin of 13.44%. Medpace's return on equity of 110.15% beat Sotera Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.67%	110.15%	24.84%
Sotera Health	13.44%	40.12%	7.55%

Medpace currently has a consensus target price of $595.20, indicating a potential downside of 4.14%. Sotera Health has a consensus target price of $21.50, indicating a potential upside of 11.95%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

Medpace beats Sotera Health on 11 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Revvity?

Revvity (NYSE:RVTY) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

Revvity has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revvity	$2.86B	5.82	$241.20M	$2.10	70.98
Sotera Health	$1.16B	4.71	$77.94M	$0.57	33.69

Sotera Health has a net margin of 13.44% compared to Revvity's net margin of 8.16%. Sotera Health's return on equity of 40.12% beat Revvity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Revvity	8.16%	8.34%	5.01%
Sotera Health	13.44%	40.12%	7.55%

Revvity has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market.

In the previous week, Revvity had 11 more articles in the media than Sotera Health. MarketBeat recorded 14 mentions for Revvity and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.93 beat Revvity's score of 0.78 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Revvity	4 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Revvity currently has a consensus target price of $116.57, indicating a potential downside of 21.80%. Sotera Health has a consensus target price of $21.50, indicating a potential upside of 11.95%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts clearly believe Sotera Health is more favorable than Revvity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revvity	0 Sell rating(s)	14 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

86.7% of Revvity shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 0.9% of Revvity shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Sotera Health beats Revvity on 10 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Icon?

Icon (NASDAQ:ICLR) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

Icon has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.61	$229.34M	$4.26	40.63
Sotera Health	$1.16B	4.71	$77.94M	$0.57	33.69

Sotera Health has a net margin of 13.44% compared to Icon's net margin of 3.99%. Sotera Health's return on equity of 40.12% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Sotera Health	13.44%	40.12%	7.55%

In the previous week, Sotera Health had 1 more articles in the media than Icon. MarketBeat recorded 3 mentions for Sotera Health and 2 mentions for Icon. Icon's average media sentiment score of 1.32 beat Sotera Health's score of 0.93 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Icon presently has a consensus target price of $170.40, suggesting a potential downside of 1.56%. Sotera Health has a consensus target price of $21.50, suggesting a potential upside of 11.95%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Icon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

95.6% of Icon shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 44.0% of Icon shares are held by insiders. Comparatively, 15.4% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Icon has a beta of 1.2, meaning that its stock price is 20% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, meaning that its stock price is 77% more volatile than the broader market.

Summary

Sotera Health beats Icon on 9 of the 17 factors compared between the two stocks.

How does Sotera Health compare to Charles River Laboratories International?

Sotera Health (NASDAQ:SHC) and Charles River Laboratories International (NYSE:CRL) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

Sotera Health has a net margin of 13.44% compared to Charles River Laboratories International's net margin of -5.96%. Sotera Health's return on equity of 40.12% beat Charles River Laboratories International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	13.44%	40.12%	7.55%
Charles River Laboratories International	-5.96%	15.75%	6.51%

Sotera Health has higher earnings, but lower revenue than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.71	$77.94M	$0.57	33.69
Charles River Laboratories International	$4.02B	3.38	-$144.34M	-$4.85	N/A

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Sotera Health presently has a consensus target price of $21.50, suggesting a potential upside of 11.95%. Charles River Laboratories International has a consensus target price of $265.69, suggesting a potential downside of 6.56%. Given Sotera Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Sotera Health is more favorable than Charles River Laboratories International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Charles River Laboratories International	1 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.67

Sotera Health has a beta of 1.77, suggesting that its share price is 77% more volatile than the broader market. Comparatively, Charles River Laboratories International has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

In the previous week, Charles River Laboratories International had 2 more articles in the media than Sotera Health. MarketBeat recorded 5 mentions for Charles River Laboratories International and 3 mentions for Sotera Health. Charles River Laboratories International's average media sentiment score of 1.07 beat Sotera Health's score of 0.93 indicating that Charles River Laboratories International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Charles River Laboratories International	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sotera Health beats Charles River Laboratories International on 11 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

Bio-Techne has a net margin of 14.97% compared to Sotera Health's net margin of 13.44%. Sotera Health's return on equity of 40.12% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	14.97%	13.23%	10.61%
Sotera Health	13.44%	40.12%	7.55%

Bio-Techne presently has a consensus target price of $68.92, suggesting a potential downside of 4.81%. Sotera Health has a consensus target price of $21.50, suggesting a potential upside of 11.95%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	0 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.12
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

In the previous week, Bio-Techne had 9 more articles in the media than Sotera Health. MarketBeat recorded 12 mentions for Bio-Techne and 3 mentions for Sotera Health. Bio-Techne's average media sentiment score of 1.14 beat Sotera Health's score of 0.93 indicating that Bio-Techne is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	8 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 1.3% of Bio-Techne shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Bio-Techne has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	9.35	$181.86M	$1.15	62.96
Sotera Health	$1.16B	4.71	$77.94M	$0.57	33.69

Bio-Techne has a beta of 1.28, indicating that its stock price is 28% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market.

Summary

Bio-Techne beats Sotera Health on 10 of the 16 factors compared between the two stocks.

Get Sotera Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHC vs. The Competition

Export

Metric	Sotera Health	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.48B	$10.50B	$7.25B	$15.22B
Dividend Yield	N/A	1.46%	2.57%	12.30%
P/E Ratio	33.71	69.12	274.11	25.62
Price / Sales	4.71	107.38	632.74	86.88
Price / Cash	14.85	26.46	76.40	50.90
Price / Book	9.02	5.74	10.51	6.31
Net Income	$77.94M	$56.67B	$3.49B	$358.11M
7 Day Performance	5.18%	3.55%	0.50%	0.46%
1 Month Performance	2.15%	3.13%	-0.07%	-3.01%
1 Year Performance	18.18%	29.82%	22.64%	7.10%

Sotera Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHC Sotera Health	3.7749 of 5 stars	$19.19 -0.8%	$21.50 +12.1%	+18.6%	$5.47B	$1.16B	33.64	3,000
MEDP Medpace	2.5062 of 5 stars	$620.82 +4.3%	$595.20 -4.1%	+25.6%	$17.33B	$2.53B	36.39	6,200	Positive News Analyst Forecast
RVTY Revvity	2.5968 of 5 stars	$140.02 +9.0%	$116.57 -16.7%	+71.2%	$15.62B	$2.91B	66.68	11,000
ICLR Icon	2.2114 of 5 stars	$172.16 +1.9%	$170.40 -1.0%	+0.5%	$13.18B	$8.29B	40.41	40,100	Positive News
CRL Charles River Laboratories International	2.1764 of 5 stars	$272.98 0.0%	$265.69 -2.7%	+80.5%	$13.03B	$4.00B	N/A	19,700	Positive News Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHC) was last updated on 9/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sotera Health (SHC) Competitors

SHC vs. MEDP, RVTY, ICLR, CRL, and TECH

How does Sotera Health compare to Medpace?

Summary

How does Sotera Health compare to Revvity?

Summary

How does Sotera Health compare to Icon?

Summary

How does Sotera Health compare to Charles River Laboratories International?

Summary

How does Sotera Health compare to Bio-Techne?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sotera Health (SHC) Competitors

SHC vs. MEDP, RVTY, ICLR, CRL, and TECH

How does Sotera Health compare to Medpace?

Do institutionals & insiders have more ownership in MEDP or SHC?

Does the media favor MEDP or SHC?

Which has preferable valuation and earnings, MEDP or SHC?

Which has more volatility & risk, MEDP or SHC?

Is MEDP or SHC more profitable?

Do analysts prefer MEDP or SHC?

Summary

How does Sotera Health compare to Revvity?

Which has stronger valuation and earnings, RVTY or SHC?

Is RVTY or SHC more profitable?

Which has more risk and volatility, RVTY or SHC?

Does the media refer more to RVTY or SHC?

Do analysts prefer RVTY or SHC?

Do insiders & institutionals believe in RVTY or SHC?

Summary

How does Sotera Health compare to Icon?

Which has better earnings and valuation, ICLR or SHC?

Is ICLR or SHC more profitable?

Does the media refer more to ICLR or SHC?

Do analysts rate ICLR or SHC?

Do insiders and institutionals hold more shares of ICLR or SHC?

Which has more risk and volatility, ICLR or SHC?

Summary

How does Sotera Health compare to Charles River Laboratories International?

Is SHC or CRL more profitable?

Which has higher earnings & valuation, SHC or CRL?

Do insiders and institutionals have more ownership in SHC or CRL?

Do analysts recommend SHC or CRL?

Which has more volatility & risk, SHC or CRL?

Does the media favor SHC or CRL?

Summary

How does Sotera Health compare to Bio-Techne?

Is TECH or SHC more profitable?

Do analysts rate TECH or SHC?

Does the media prefer TECH or SHC?

Do insiders & institutionals hold more shares of TECH or SHC?

Which has stronger valuation & earnings, TECH or SHC?

Which has more volatility & risk, TECH or SHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools